Premium
Ardea Biosciences, Inc. (MM) (RDEA)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Ardea Biosciences, Inc. PR Newswire DALLAS, May 1, 2012 DALLAS, May 1, 2012 /PRNewswire/ -- Securities...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Ardea Biosciences, Inc. (“Ardea” or the “Company”...
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Ardea Biosciences, Inc. in Connection with the Sale of the Company to...
Law Office of Brodsky & Smith, LLC Announces Investigation of Ardea Biosciences, Inc. PR Newswire BALA CYNWYD, Pa., April 24, 2012 BALA CYNWYD, Pa., April 24, 2012 /PRNewswire/ -- Law office of...
Law Offices of Howard G. Smith announces that it is investigating potential claims against the Board of Directors of Ardea Biosciences, Inc. (“Ardea” or the “Company”) (NASDAQ:...
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/rdea) is investigating potential claims against the board of directors of Ardea Biosciences, Inc. (“Ardea” or the “Company”...
Levi & Korsinsky is investigating the Board of Directors of Ardea Biosciences, Inc. (“Ardea” or the “Company”) (Nasdaq: RDEA) for possible breaches of fiduciary duty and other...
Shareholder rights firm Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of the law by members of the board of...
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Ardea Biosciences, Inc. (“Ardea” or the...
Harwood Feffer LLP Announces Investigation of Ardea Biosciences, Inc. PR Newswire NEW YORK, April 23, 2012 NEW YORK, April 23, 2012 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
